Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
2021 · Nature Medicine · 558 citations
https://doi.org/10.1038/s41591-021-01548-7
K
Karina-Doris Vihta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
3.5K
Citations
25
h-index
33
i10-index
Karina-Doris Vihta is an academic researcher from National Institute for Health Research. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 25, co-authored 51 publications.
ORCID: 0000-0002-4111-7577Papers by this author
worksAntibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
2022 · Nature Medicine · 266 citations
https://doi.org/10.1038/s41591-022-01721-6
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
2021 · Nature Communications · 146 citations
https://doi.org/10.1038/s41467-021-26479-2
The plasmidome associated with Gram-negative bloodstream infections: A large-scale observational study using complete plasmid assemblies
2024 · Nature Communications · 26 citations
https://doi.org/10.1038/s41467-024-45761-7
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance
2021 · The Lancet Regional Health - Europe · 25 citations
https://doi.org/10.1016/j.lanepe.2021.100282
SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort
2024 · BMC Medicine · 14 citations
https://doi.org/10.1186/s12916-024-03351-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat